Mukka Proteins Limited(IN:MUKKA)
₹26.58-0.26 (-0.97%)
IN:MUKKA
Mukka Proteins Limited financials statements
₹26.58
At close:-0.26 (-0.97%)
Want to see IN:MUKKA full AI Analyst Report?
Mukka Proteins Limited (MUKKA) Ratios
1 Followers
Mukka Proteins Limited Ratios
IN:MUKKA's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:MUKKA's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.23 | 1.52 | 1.57 | 1.15 | 1.05 |
| Quick Ratio | 0.41 | 0.59 | 0.75 | 0.58 | 0.44 |
| Cash Ratio | 0.06 | 0.01 | 0.18 | 0.07 | 0.04 |
| Solvency Ratio | 0.06 | 0.10 | 0.15 | 0.13 | 0.11 |
| Operating Cash Flow Ratio | -0.15 | -0.18 | -0.29 | -0.16 | 0.00 |
| Short-Term Operating Cash Flow Coverage | -0.21 | -0.25 | -0.42 | -0.26 | 0.00 |
| Net Current Asset Value | ₹ 1.96B | ₹ 3.06B | ₹ 2.84B | ₹ 318.29M | ₹ -110.22M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.42 | 0.39 | 0.48 | 0.45 |
| Debt-to-Equity Ratio | 1.56 | 1.03 | 0.92 | 2.07 | 1.95 |
| Debt-to-Capital Ratio | 0.61 | 0.51 | 0.48 | 0.67 | 0.66 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.01 | 0.02 | 0.04 | 0.07 |
| Financial Leverage Ratio | 3.25 | 2.44 | 2.38 | 4.30 | 4.37 |
| Debt Service Coverage Ratio | 0.16 | 0.17 | 0.29 | 0.29 | 0.25 |
| Interest Coverage Ratio | 1.83 | 5.35 | 3.75 | 3.67 | 3.71 |
| Debt to Market Cap | 1.39 | 0.45 | 0.42 | 0.27 | 0.19 |
| Interest Debt Per Share | 27.84 | 16.35 | 17.27 | 13.30 | 8.40 |
| Net Debt to EBITDA | 4.95 | 4.74 | 2.22 | 2.59 | 2.97 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.37% | 23.03% | 12.22% | 11.62% | 10.44% |
| EBIT Margin | 8.88% | 8.08% | 7.93% | 7.29% | 6.06% |
| EBITDA Margin | 10.03% | 9.43% | 8.83% | 8.32% | 7.18% |
| Operating Profit Margin | 6.76% | 19.82% | 6.83% | 5.23% | 4.69% |
| Pretax Profit Margin | 5.18% | 5.99% | 6.34% | 5.70% | 4.70% |
| Net Profit Margin | 3.59% | 4.62% | 5.08% | 3.81% | 3.16% |
| Continuous Operations Profit Margin | 3.94% | 4.78% | 5.39% | 4.11% | 3.37% |
| Net Income Per EBT | 69.28% | 77.09% | 80.10% | 66.84% | 67.28% |
| EBT Per EBIT | 76.69% | 30.22% | 92.82% | 108.98% | 100.16% |
| Return on Assets (ROA) | 3.21% | 4.32% | 7.45% | 7.66% | 6.17% |
| Return on Equity (ROE) | 10.43% | 10.54% | 17.69% | 32.98% | 26.95% |
| Return on Capital Employed (ROCE) | 17.13% | 42.86% | 22.44% | 35.11% | 30.35% |
| Return on Invested Capital (ROIC) | 5.68% | 17.40% | 10.29% | 10.29% | 9.02% |
| Return on Tangible Assets | 3.24% | 4.34% | 7.45% | 7.66% | 6.17% |
| Earnings Yield | 9.41% | 4.69% | 8.07% | 4.74% | 2.60% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.54 | 4.64 | 7.45 | 8.94 | 11.51 |
| Payables Turnover | 5.10 | 5.46 | 8.89 | 7.81 | 7.03 |
| Inventory Turnover | 1.43 | 1.37 | 2.86 | 4.45 | 4.16 |
| Fixed Asset Turnover | 6.94 | 10.66 | 16.52 | 13.87 | 9.43 |
| Asset Turnover | 0.89 | 0.94 | 1.47 | 2.01 | 1.95 |
| Working Capital Turnover Ratio | 5.23 | 3.30 | 7.71 | 30.95 | 565.21 |
| Cash Conversion Cycle | 231.72 | 277.78 | 135.53 | 76.16 | 67.52 |
| Days of Sales Outstanding | 48.44 | 78.73 | 49.03 | 40.81 | 31.71 |
| Days of Inventory Outstanding | 254.86 | 265.86 | 127.55 | 82.06 | 87.70 |
| Days of Payables Outstanding | 71.58 | 66.81 | 41.05 | 46.72 | 51.89 |
| Operating Cycle | 303.30 | 344.59 | 176.57 | 122.88 | 119.41 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.30 | -3.73 | -6.66 | -2.98 | 0.01 |
| Free Cash Flow Per Share | -9.92 | -4.54 | -7.44 | -3.35 | -0.29 |
| Dividend Paid and CapEx Coverage Ratio | -1.15 | -4.64 | -8.54 | -7.98 | 0.03 |
| Capital Expenditure Coverage Ratio | -1.15 | -4.64 | -8.54 | -7.98 | 0.03 |
| Operating Cash Flow Coverage Ratio | -0.20 | -0.25 | -0.41 | -0.24 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.11 | -0.11 | -0.11 | -0.06 | 0.00 |
| Free Cash Flow Yield | -53.65% | -13.74% | -19.35% | -7.93% | -0.68% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.63 | 21.30 | 12.40 | 21.09 | 38.41 |
| Price-to-Sales (P/S) Ratio | 0.38 | 0.98 | 0.63 | 0.80 | 1.21 |
| Price-to-Book (P/B) Ratio | 1.11 | 2.25 | 2.19 | 6.96 | 10.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.86 | -7.28 | -5.17 | -12.61 | -146.90 |
| Price-to-Operating Cash Flow Ratio | -3.49 | -8.84 | -5.77 | -14.19 | 5108.35 |
| Price-to-Earnings Growth (PEG) Ratio | 0.87 | -0.43 | 0.23 | 0.26 | 0.14 |
| Enterprise Value Multiple | 8.75 | 15.17 | 9.35 | 12.26 | 19.88 |
| Enterprise Value | 12.72B | 14.40B | 11.39B | 11.79B | 10.93B |
| EV to EBITDA | 8.75 | 15.17 | 9.35 | 12.26 | 19.88 |
| EV to Sales | 0.88 | 1.43 | 0.83 | 1.02 | 1.43 |
| EV to Free Cash Flow | -4.29 | -10.58 | -6.78 | -15.99 | -172.74 |
| EV to Operating Cash Flow | -8.03 | -12.86 | -7.57 | -17.99 | 6007.02 |
| Tangible Book Value Per Share | 17.19 | 15.00 | 18.07 | 6.45 | 4.31 |
| Shareholders’ Equity Per Share | 16.68 | 14.70 | 17.53 | 6.07 | 4.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.20 | 0.15 | 0.28 | 0.28 |
| Revenue Per Share | 48.45 | 33.58 | 61.06 | 52.56 | 34.82 |
| Net Income Per Share | 1.74 | 1.55 | 3.10 | 2.00 | 1.10 |
| Tax Burden | 0.69 | 0.77 | 0.80 | 0.67 | 0.67 |
| Interest Burden | 0.58 | 0.74 | 0.80 | 0.78 | 0.77 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | 0.08 | 0.04 | 0.04 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -3.04 | -2.41 | -2.15 | -1.49 | 0.01 |
Currency in INR
